middle.news
AdAlta and Partners Target Cell Therapy Scale-Up with Automated IRO Platform
9:42am on Tuesday 21st of April, 2026 AEST
•
Biotechnology
Read Story
AdAlta and Partners Target Cell Therapy Scale-Up with Automated IRO Platform
9:42am on Tuesday 21st of April, 2026 AEST
Key Points
MoU signed to bring IRO platform to Asia Pacific
IRO targets 10-50x throughput increase and 30-50% cost savings
Supports AdAlta’s strategy to scale solid cancer cell therapies
Positions CTPL as leading Asia-Pacific cell therapy manufacturer
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE